Description
General Product Information
Alpha BioPharma PT-141 is supplied in 10 mg per vial. The single-vial package includes one ampoule of sterile water for injection.
PT-141 is commonly discussed in general contexts in relation to sexual response and sexual desire. Available sources describe PT-141 as bremelanotide, a synthetic peptide belonging to the melanocortin class. At the same time, it is a compound for which health risks, legal considerations, and product traceability should be taken seriously.
This page is intended to provide general product information for individuals seeking information about product specifications and important considerations. It does not constitute medical advice, usage instructions, or dosage recommendations.
What is PT-141?
PT-141 is the commonly used name for bremelanotide. Available sources describe bremelanotide as a melanocortin receptor agonist. In an official medical context, bremelanotide has been approved in the United States for a specific indication in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD). This is different from a general approval as an erectile dysfunction treatment for men.
The response to this type of product may vary significantly from person to person and depends on factors such as overall health, medical history, medication use, and other individual circumstances.
Product Specifications
Brand: Alpha BioPharma
Product: PT-141
Active Ingredient: Bremelanotide / PT-141
Strength: 10 mg per vial
Packaging: Single-vial package
Included: 1 ampoule of sterile water for injection
Category: Peptide / Melanocortin-Related Compound
Target Audience: General product information for informational purposes only
Relevance Within General Product Information
Some individuals are interested in PT-141 because of its potential association with:
- sexual response
- sexual desire
- neurohormonal regulation
- general physiological processes related to sexual function
These points describe the general contexts in which PT-141 is commonly discussed. They do not guarantee any results and should not be interpreted as usage advice.
What Should You Consider?
When evaluating products in this category, it is important to look beyond the intended purpose. Consider the following:
- product origin and traceability
- accurate labeling and packaging
- batch number and expiration date
- condition of the vial and seal
- included accessories and components
- your personal health condition
- existing medical conditions or medication use
- cardiovascular considerations
Always consult a qualified healthcare professional if you have questions regarding your health or potential risks.
Quality and Traceability
At Alpha BioPharma, we believe that clear product information and traceability are essential. Carefully inspect each product before storage or further evaluation.
Please verify the following:
- correct product name
- strength per vial
- batch number
- expiration date
- condition of the packaging and seal
- clear product labeling
- available batch or certificate of analysis (COA)
Do not use any product if its origin, composition, or quality cannot be verified.
Potential Risks
Available official and medical sources mention potential side effects and important considerations, including:
- nausea
- headache
- injection site reactions
- flushing
- temporary increase in blood pressure
- reduced heart rate following administration
- changes in skin pigmentation or darkening of certain skin areas
If you experience symptoms such as chest pain, shortness of breath, severe headaches, significant cardiovascular symptoms, or any other serious health concerns, seek immediate medical attention.
Usage & Dosage
The commonly used dosage ranges from 0.5 to 2 mg of PT-141 per injection, administered subcutaneously.
It is generally recommended to begin with a lower dose to assess individual sensitivity (e.g., 0.5–1 mg).
General Administration Instructions:
- Reconstitute the freeze-dried powder with bacteriostatic water (1–2 ml).
- Administer the injection subcutaneously into the abdomen or thigh using an insulin syringe.
- Preferably administer 1–3 hours before the desired effect period.
- Do not use more than once within a 24-hour period.
Can't figure it out? Use our convenient Peptide Calculator!
⚠️ Always follow the instructions for use. Do not use if you are unsure about sterile injection techniques or proper dosing.
Competitive Sports and Doping
Athletes who are subject to anti-doping regulations should exercise extra caution. Always consult the latest rules published by the relevant sports federation or anti-doping organization before drawing conclusions about the status of any specific substance or compound.
Athletes are solely responsible for any substances detected in their bodies.
Storage
Always follow the storage instructions provided on the product label and packaging. Also inspect the overall condition of the vial, cap, and included components. Do not use the product after the expiration date or if the packaging is damaged or appears compromised.
Instructions: Preparing a Peptide for Use
What You Will Receive:
- 1 vial containing freeze-dried peptide powder
- 1 ampoule of sterile water
⚠️ Please note: Insulin syringes are not included and must be purchased separately. You can purchase insulin syringes here.
Step-by-Step Instructions
- Remove the flip-off cap from the peptide vial.
- Draw 1 ml of sterile water into an insulin syringe.
- Slowly add the sterile water to the vial by directing it against the inside wall of the vial rather than directly onto the powder.
- Allow the solution to dissolve naturally. Do not shake the vial; gently swirling it is acceptable.
- Ready for use once the powder has completely dissolved.
Dosage Explanation (Calculation Example)
- With 1 ml of solution, 0.1 ml equals one-tenth of the total contents of the vial.
- 5 mg peptide = 0.1 ml = 0.5 mg
- 10 mg peptide = 0.1 ml = 1 mg
Can't figure it out? Use our convenient Peptide Calculator!
Reviews
There are no reviews yet.